Question 1

How many shares of EPRX does UBS Group AG own?

Accepted Answer

As of 2026-Q2, UBS Group AG holds 519,211 shares of EPRX (EUPRAXIA PHARMACEUTICALS INC).

Question 2

What is UBS Group AG's EPRX position worth?

Accepted Answer

As of 2026-Q2, UBS Group AG's EPRX position is worth $3.4M.

Question 3

Is UBS Group AG buying or selling EPRX?

Accepted Answer

In 2026-Q2, UBS Group AG decreased their EPRX position (-31.9% change in shares).

Question 4

When did UBS Group AG first buy EPRX?

Accepted Answer

Based on available 13F filings, UBS Group AG first reported a position in EPRX in 2024-Q2. They have held the position across 9 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Decreased	519,211	-31.9%	$3.4M	0.0%	$6.61	0
2026-Q1	Increased	762,635	+246.6%	$5.5M	0.0%	$8.02	44
2025-Q4	Increased	220,024	+129.8%	$1.7M	0.0%	$7.59	41
2025-Q3	Increased	95,756	+155.4%	$564,960	0.0%	$5.75	39
2025-Q2	Decreased	37,499	-26.8%	$215,994	0.0%	$5.30	0
2025-Q1	Increased	51,199	+82.8%	$167,933	0.0%	$3.38	24
2024-Q4	Decreased	28,000	-15.2%	$88,760	0.0%	$3.09	0
2024-Q3	Increased	33,000	+11.5%	$86,790	0.0%	$2.63	16
2024-Q2	New	29,590	-	$76,342	0.0%	$2.58	33

EPRX9 quarters

EPRX
9 quarters